These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Risperidone vs. placebo for schizophrenia. Kripke C Am Fam Physician; 2010 May; 81(9):1096. PubMed ID: 20433125 [No Abstract] [Full Text] [Related]
24. Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication. Citrome L Int J Clin Pract; 2010 Jan; 64(2):216-39. PubMed ID: 19886879 [TBL] [Abstract][Full Text] [Related]
25. Risperidone and remoxipride for schizophrenia. Drug Ther Bull; 1993 Dec; 31(26):101-2. PubMed ID: 7508364 [No Abstract] [Full Text] [Related]
26. Use of long-acting risperidone. Parker G Psychiatr Serv; 2005 Jan; 56(1):105-6; author reply 106-7. PubMed ID: 15637203 [No Abstract] [Full Text] [Related]
27. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia. Fowler JA; Bettinger TL; Argo TR Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262 [TBL] [Abstract][Full Text] [Related]
28. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia. Dursun S J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780 [No Abstract] [Full Text] [Related]
29. A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia. Gopal S; Vijapurkar U; Lim P; Morozova M; Eerdekens M; Hough D J Psychopharmacol; 2011 May; 25(5):685-97. PubMed ID: 20615933 [TBL] [Abstract][Full Text] [Related]
30. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Keith S Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665 [TBL] [Abstract][Full Text] [Related]
31. Risperidone long-acting injection: a brief overview. Lemon M S D J Med; 2004 May; 57(5):171-2. PubMed ID: 15181859 [No Abstract] [Full Text] [Related]
32. Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent. Prescrire Int; 2007 Dec; 16(92):236-7. PubMed ID: 18092400 [TBL] [Abstract][Full Text] [Related]
37. New drug offers hope for people with schizophrenia. J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676 [No Abstract] [Full Text] [Related]
38. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. Berwaerts J; Cleton A; Rossenu S; Talluri K; Remmerie B; Janssens L; Boom S; Kramer M; Eerdekens M J Psychopharmacol; 2010 Jul; 24(7):1011-8. PubMed ID: 19825908 [TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343 [TBL] [Abstract][Full Text] [Related]
40. Schizophrenia and severe tardive dyskinesia responsive to risperidone. Kopala LC; Honer WG J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]